5AM Venture Management, LLC - Q2 2020 holdings

$457 Million is the total value of 5AM Venture Management, LLC's 9 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 12.5% .

 Value Shares↓ Weighting
AKUS NewAkouos Inc.$103,630,0004,605,784
+100.0%
22.70%
APRE SellAprea Therapeutics, Inc.$85,807,000
-13.5%
2,212,654
-22.4%
18.79%
-38.8%
FIXX  Homology Medicines, Inc.$84,091,000
-2.3%
5,535,9190.0%18.42%
-30.9%
IDYA  IDEAYA Biosciences, Inc.$49,210,000
+244.9%
3,463,0660.0%10.78%
+143.9%
CABA  Cabaletta Bio, Inc.$40,876,000
+52.6%
3,669,2630.0%8.95%
+7.9%
ARVN  Arvinas, Inc.$33,540,000
-16.8%
1,000,0000.0%7.34%
-41.1%
SCPH BuyscPharmaceuticals Inc.$28,200,000
+17.1%
3,831,474
+17.8%
6.18%
-17.1%
CRNX SellCrinetics Pharmaceuticals, Inc.$23,867,000
-12.8%
1,362,286
-26.8%
5.23%
-38.3%
CDTX  Cidara Therapeutics, Inc.$7,404,000
+48.8%
2,006,5110.0%1.62%
+5.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HOMOLOGY MEDICINES INC16Q3 202326.6%
ARVINAS INC16Q3 202314.3%
Crinetics Pharmaceuticals, Inc.16Q3 202312.8%
SCPHARMACEUTICALS INC16Q3 20237.5%
CIDARA THERAPEUTICS INC16Q3 20231.7%
IDEAYA BIOSCIENCES INC14Q1 202311.4%
VOR BIOPHARMA INC11Q3 202351.9%
CABALETTA BIO INC11Q2 202214.2%
AKOUOS INC10Q3 202227.7%
IMPEL PHARMACEUTICALS INC10Q3 20237.1%

View 5AM Venture Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-03
13F-HR2021-11-15

View 5AM Venture Management, LLC's complete filings history.

Compare quarters

Export 5AM Venture Management, LLC's holdings